Learning styles: a review of theory, application, and best practices F Romanelli, E Bird, M Ryan American journal of pharmaceutical education 73 (1), 2009 | 489 | 2009 |
Long-term cognitive impact of anticholinergic medications in older adults KA Bottiggi, JC Salazar, L Yu, AM Caban-Holt, MS Mendiondo, FA Schmitt, ... The American journal of geriatric psychiatry 14 (11), 980-984, 2006 | 122 | 2006 |
Effectiveness of a pharmacist‐based smoking‐cessation program and its impact on quality of life AJ Zillich, M Ryan, A Adams, B Yeager, K Farris Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 22 (6 …, 2002 | 104 | 2002 |
Drug treatment strategies for depression in Parkinson disease M Ryan, CV Eatmon, JT Slevin Expert opinion on pharmacotherapy 20 (11), 1351-1363, 2019 | 97 | 2019 |
Therapeutic dilemma: the use of anticonvulsants in HIV-positive individuals F Romanelli, HR Jennings, A Nath, M Ryan, J Berger Neurology 54 (7), 1404-1407, 2000 | 77 | 2000 |
Clinical pharmacy education in China M Ryan, H Shao, L Yang, XY Nie, SD Zhai, LW Shi, WC Lubawy American journal of pharmaceutical education 72 (6), 2008 | 75 | 2008 |
Factors leading patients to discontinue multiple sclerosis therapies KK Daugherty, JS Butler, M Mattingly, M Ryan Journal of the American Pharmacists Association 45 (3), 371-375, 2005 | 73 | 2005 |
Correlation of levetiracetam concentrations between serum and saliva SA Grim, M Ryan, MV Miles, PH Tang, RH Strawsburg, TJ degrauw, ... Therapeutic drug monitoring 25 (1), 61-66, 2003 | 70 | 2003 |
Use and monitoring of bromides in epilepsy treatment M Ryan, RJ Baumann Pediatric neurology 21 (2), 523-528, 1999 | 61 | 1999 |
A comparison of medication adherence/persistence for asthma and chronic obstructive pulmonary disease in the United Kingdom JR Covvey, AB Mullen, M Ryan, DT Steinke, BF Johnston, FT Wood, ... International journal of clinical practice 68 (10), 1200-1208, 2014 | 60 | 2014 |
Restless legs syndrome M Ryan, JT Slevin American journal of health-system pharmacy 63 (17), 1599-1612, 2006 | 56 | 2006 |
Non‐ergot dopamine agonist‐induced sleep attacks M Ryan, JT Slevin, A Wells Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 20 (6 …, 2000 | 55 | 2000 |
A brief review of the pharmacologic and therapeutic aspects of memantine in Alzheimer’s disease F Schmitt, M Ryan, G Cooper Expert Opinion on Drug Metabolism & Toxicology 3 (1), 135-141, 2007 | 54 | 2007 |
Topiramate concentration in saliva: an alternative to serum monitoring MV Miles, PH Tang, TA Glauser, MA Ryan, SA Grim, RH Strawsburg, ... Pediatric neurology 29 (2), 143-147, 2003 | 54 | 2003 |
Systemic metabolic effects of combined insulin-like growth factor–I and growth hormone therapy in patients who have sustained acute traumatic brain injury J Hatton, R Kryscio, M Ryan, L Ott, B Young Journal of neurosurgery 105 (6), 843-852, 2006 | 53 | 2006 |
Correlation of lamotrigine concentrations between serum and saliva M Ryan, SA Grim, MV Miles, PH Tang, TA Fakhoury, RH Strawsburg, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 23 (12 …, 2003 | 51 | 2003 |
Factors associated with pharmacy student interest in international study C Owen, P Breheny, R Ingram, W Pfeifle, J Cain, M Ryan American Journal of Pharmaceutical Education 77 (3), 54, 2013 | 46 | 2013 |
Current practices in global/international advanced pharmacy practice experiences: preceptor and student considerations EK Dornblaser, A Ratka, SE Gleason, DN Ombengi, T Tofade, PR Wigle, ... American journal of pharmaceutical education 80 (3), 39, 2016 | 43 | 2016 |
Stability of salivary concentrations of the newer antiepileptic drugs in the postal system MD Jones, M Ryan, MV Miles, PH Tang, TA Fakhoury, JG Ton, ... Therapeutic drug monitoring 27 (5), 576-579, 2005 | 41 | 2005 |
Chronic inflammatory demyelinating polyneuropathy: considerations for diagnosis, management, and population health M Ryan, SJ Ryan Am J Manag Care 24 (17 Suppl), S371-9, 2018 | 38 | 2018 |